Position in LFCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$391,154
-$570,740 QoQ
Shares Held
105,149
-10.6% QoQ
Ownership
0.278%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $21,852,087 across 7 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
105,781 | $8,433,919 | |
| 2 | HROW |
Harrow, Inc.
|
116,908 | $4,965,082 | |
| 3 | ETON |
Eton Pharmaceuticals, Inc.
|
73,101 | $2,646,256 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
26,976 | $2,233,073 | |
| 5 | DERM |
Journey Medical Corp
|
295,663 | $2,093,294 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
7,486 | $1,261,690 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
1,972 | $218,773 |
All Filings in LFCR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $391,154 | 105,149 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $961,894 | 117,591 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $189,762 | 25,783 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $271,792 | 33,472 | Shares | Defined | 2025-08-13 | |
| 2024-12-31 | $320,574 | 43,146 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $372,338 | 75,525 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $82,705 | 16,122 | Shares | Defined | 2024-08-13 | |
| 2023-12-31 | $332,415 | 53,702 | Shares | Defined | 2024-02-13 | |
| 2023-03-31 | $245,397 | 64,920 | Shares | Defined | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||